The withdrawal has been initiated due to a surplus of available updated vaccines since the pandemic, the company said in a statement.
AstraZeneca vaccine supplied as Covishield in India. (Supplied)
AstraZeneca started global withdrawal of its Covid-19 vaccine, sold in India as “Covishield’” in partnership with Serum Institute of India. The reason is a surplus of available updated vaccines since the pandemic, the company said in a statement. However, it comes days after AstraZeneca admitted to rare side effects of blood clotting and low platelet counts due to its vaccine.